West Pharmaceutical Services Balance Sheet Health
Financial Health criteria checks 6/6
West Pharmaceutical Services has a total shareholder equity of $2.8B and total debt of $202.6M, which brings its debt-to-equity ratio to 7.4%. Its total assets and total liabilities are $3.7B and $923.0M respectively. West Pharmaceutical Services's EBIT is $594.1M making its interest coverage ratio -30.9. It has cash and short-term investments of $490.9M.
Key information
7.4%
Debt to equity ratio
US$202.60m
Debt
| Interest coverage ratio | -30.9x |
| Cash | US$490.90m |
| Equity | US$2.75b |
| Total liabilities | US$923.00m |
| Total assets | US$3.68b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: WST *'s short term assets ($1.6B) exceed its short term liabilities ($516.5M).
Long Term Liabilities: WST *'s short term assets ($1.6B) exceed its long term liabilities ($406.5M).
Debt to Equity History and Analysis
Debt Level: WST * has more cash than its total debt.
Reducing Debt: WST *'s debt to equity ratio has reduced from 13.1% to 7.4% over the past 5 years.
Debt Coverage: WST *'s debt is well covered by operating cash flow (346.7%).
Interest Coverage: WST * earns more interest than it pays, so coverage of interest payments is not a concern.